Dimensions Health Centres Expands Executive Leadership Team
Dimensions Health Centres (“Dimensions”), a psychedelic wellness company focused on integrating neuroscience with traditional healing practices, today announced the expansion of its executive leadership team with two new appointments.
Dimensions Health Centres to Provide Funding for Psychedelics Research Collaborative at Queen’s University
Dimensions Health Centres (“Dimensions”), a psychedelic wellness company offering immersive retreats for reset and renewal, will provide funding to the Faculty of Health Sciences at Queen’s University, to help launch a collaborative space for research and innovation in the field of psychedelics.
Dimensions Health Centres Announces Closing of First Treatment Center on Maple Lake in the Alongonquin Highlands
Dimensions Health Centres (“Dimensions”), a psychedelic treatment company focused on inpatient treatment integrating neuroscience with traditional healing practices, officially announced its closure on a 40-acre property on Maple Lake in the Algonquin Highlands, two hours northeast of Toronto. The announcement comes on the heels of Dimensions’ recent initial oversubscribed funding round and represents the Company’s next major step in a series of forthcoming developments.
Dimensions Health Centres Announces Company Formation, Closes Oversubscribed Initial Funding Round
Dimensions Health Centres (“Dimensions”), a psychedelic treatment company, officially announced the company formation and subsequent closure of an initial, oversubscribed round of funding. The management team is led by CEO and co-founder Christopher Dawson, COO and co-founder Andrew Galloway, and Chairperson and co-founder David Heden.
Dimensions will offer an innovative and comprehensive